Cite
HARVARD Citation
Ashina, M. et al. (2018). Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study. Cephalalgia. pp. 1611-1621. [Online].